Updated

GSK announced it will cut 641 jobs as part of a restructuring of its vaccine manufacturing operations, according to a Yahoo Finance report. The cuts reflect the pharmaceutical company's efforts to streamline production amid shifting demand dynamics in its vaccines business. The job reductions add to a broader pattern of restructuring moves among large pharmaceutical manufacturers seeking to align capacity with evolving market conditions.